Speed Medical results, Fiscal year 2021
Net profit, assets, equity and cash flow for Fiscal year 2021, against the same period a year earlier, from the published financial statements.
Net profit136 millionEGP · +71.8% vs the same period a year earlier
Total assets783 millionEGP · +49.4% vs the same period a year earlier
Shareholders' equity458 millionEGP · +38.3% vs the same period a year earlier
Operating cash flow148 millionEGP · +227.9% vs the same period a year earlier
In short
- Speed Medical's net profit for Fiscal year 2021 was about 136 million EGP, up +71.8% from 79.21 million EGP in Fiscal year 2020.
- Total assets at the end of Fiscal year 2021 were about 783 million EGP, and shareholders' equity about 458 million EGP.
- Operating cash flow for Fiscal year 2021 was positive at 148 million EGP.
Key lines against the same period a year earlier
This periodFiscal year 2020Change
Net profit136 million79.21 million+71.8%
Gross profit213 million102 million+108.4%
Total assets783 million524 million+49.4%
Total liabilities325 million193 million+68.5%
Shareholders' equity458 million331 million+38.3%
Total liabilities and equity783 million524 million+49.4%
Operating cash flow148 million-115 million+227.9%
Investing cash flow-400 million-128 million−212.3%
Financing cash flow147 million245 million−40.1%
Net change in cash-123 million38.26 million−421.0%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy